Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 1997

View Archived Issues

MMP inhibitors described by Agouron

New spironolactone formulation imparts improved bioavailability, clinical response

Crinone approved in Mexico

Generic levobunolol approved in Canada

High rating given to Saliva Diagnostic Systems' SeroStrip HIV

Organon's fertility hormone approved in Canada

Viragen opens manufacturing plant for alfa interferon

FDA approves IND for cystic fibrosis drug

Angiotech signs license agreement with Boston Scientific and Cook

Elan licenses Morphelan to Targon Corporation

Efficacy shown with roxithromycin for cardiovascular disease

The National Psoriasis Foundation warns of potential danger of OTC psoriasis product

Trovert receives Orphan Drug designation for acromegaly

P&U antioxidant shows cerebroprotective activity in rats

Alkermes issued U.S. patent for ProLease

YM90K efficacy shown in rat model of cerebral ischemia

Endothelin antagonists for cerebral ischemia

Bradykinin antagonist shows potential in stroke and ischemic disorders

NR2B-selective NMDA antagonist for occlusive stroke

YM-872 shows potential for stroke in animal models

Antiischemic activity of calmodulin antagonist reported

Medtronic Jewel AF enters clinical trials in U.S.

HIV/AIDS research contract granted to Population Council

Secreted proteins strategic alliance between Genset and Genetics Institute

AmBisome cleared by FDA

Taxotere cleared in four additional countries

Teva's problems with clindamycin

Antiinflammatory drugs in early development at Searle

Arginine mimetics from Boehringer Mannheim

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...